Inner Ear Drug Delivery
Inner Ear Drug Delivery - Related Videos
04:36
Canalostomy for Local Drug Delivery into the Inner Ear of an Adult Mouse
0 Views •
2025
This video showcases canalostomy, a procedure that allows local drug delivery into the inner ear of a mouse through the semicircular canal with minimal damage to hearing and vestibular function. This method enables the inoculation of viral vectors, pharmaceuticals, and small molecules into the mouse's inner ear.
09:34
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
0 Views •
Cited by 43 •
2018
Here we describe canalostomy procedure which allows local drug delivery into the inner ears of adult and neonatal mice through the semicircular canal with minimum damage to hearing and vestibular function. This method can be used to inoculate viral vectors, pharmaceuticals, and small molecules into the mouse inner ear.
09:18
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
0 Views •
Cited by 15 •
2017
Two microsurgery approaches for local drug delivery to the inner ear are described here and compared in terms of impact on hearing parameters, cochlear cytoarchitecture and expression of inflammatory markers.
08:25
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
0 Views •
Cited by 5 •
2014
A mouse model of human endoscopic skull base reconstruction has been developed that creates a semipermeable interface between the brain and nose using nasal mucosal grafts. This method allows researchers to study delivery to the central nervous system of high molecular weight therapeutics which are otherwise excluded by the blood-brain barrier when administered systemically.
14:55
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
0 Views •
Cited by 172 •
2013
We describe a method to target drugs to the central nervous system by either implanting a catheter or performing a bolus injection into the right lateral ventricle in mice. We focus specifically on the delivery of antisense oligonucleotides. This technique is readily adaptable to other drugs and to rats.
FAQs
A local route can place a therapeutic compound near the round window membrane, creating a more direct opportunity for exposure in nearby inner-ear tissues. However, access remains constrained by the ear’s delicate anatomy and protective barriers. The resulting distribution depends on how effectively the compound crosses or reaches target regions, which influences the biological response being investigated.
Formulation properties help determine how a drug penetrates, spreads, and remains available within the inner ear. Controlled-release systems are important because they can influence the timing and persistence of exposure rather than relying only on a single delivery event. These design factors help researchers examine whether target tissues receive an adequate, sustained therapeutic presence.
Local and systemic administration differ mainly in how compounds encounter inner-ear barriers and distribute through the body. Local placement near the round window is intended to focus exposure at the treatment site, whereas systemic circulation provides a body-wide route that may reach the ear indirectly. Comparing both routes helps balance localized access against unwanted effects elsewhere.
The cochlea and vestibular system may require different delivery considerations because they represent distinct inner-ear tissues associated with hearing and balance. A useful strategy must therefore be evaluated not only by whether a compound reaches the ear, but also by where it distributes and how long it remains. This distinction matters when studying hearing loss, tinnitus, or balance disorders.
A research workflow begins by selecting a therapeutic compound and identifying whether local placement near the round window or systemic circulation is appropriate. Investigators then consider formulation properties and whether controlled release is needed, followed by evaluating penetration, distribution, and retention in cochlear or vestibular tissues. These criteria connect delivery design with the intended biological outcome.
Inner ear drug delivery is relevant when researchers investigate hearing loss, tinnitus, balance disorders, inflammation, or inner-ear injury. The same delivery framework can support testing of emerging therapies and help assess regenerative or neuroprotective strategies. Its value lies in linking treatment exposure within cochlear or vestibular tissues to disease-specific questions while potentially limiting effects in other parts of the body.
Studies can use delivery outcomes to determine whether a compound reaches the intended inner-ear region, how broadly it distributes, and how long exposure persists. Those observations help interpret therapeutic potential and guide formulation or route selection. In otology, such evidence can inform development of treatments designed for localized action rather than relying solely on systemic exposure.